Yazan Alsayed

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1

John D. Shaughnessy, Fenghuang Zhan, Bart Burington et al. · Blood · 2006 · 916 citations

Life Sciences, Genetics, Molecular Biology +12

Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)–dependent migration and homing in multiple myeloma

Yazan Alsayed, Hai T. Ngo, Judith Runnels et al. · Blood · 2006 · 479 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents

Saad Z. Usmani, Christoph Heuck, Alyson E. Mitchell et al. · Haematologica · 2012 · 389 citations · Full text

Medicine, Hematology, Oncology +17

Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3

Bart Barlogie, Elias Anaissie, Frits van Rhee et al. · British Journal of Haematology · 2007 · 326 citations · Full text

Medicine, Hematology, Oncology +17

Activation of the p38 Mitogen-activated Protein Kinase by Type I Interferons

Shahab Uddin, Beata Majchrzak, Joanna Woodson et al. · Journal of Biological Chemistry · 1999 · 228 citations · Full text

Life Sciences, Immunology, Molecular Biology +17